Last Updated : July 27, 2024
We have identified post–COVID-19 condition as a priority area given the identified needs across many jurisdictions around how to address uncertainty and how to plan for issues related to prevention, clinical classification, diagnosis, treatment, and management of this condition. In response, we have convened a pan-Canadian Stakeholder Panel to help ensure the highest priority research areas are identified, and addressed, and that Canadian decision-makers have access to the highest quality evidence to support their range of information needs. The Pan-Canadian Stakeholder Panel on Post–COVID-19 Condition provides support for the overall direction of a Condition-Level Review on this topic, which aims to identify, appraise, assess, and make accessible, evidence and information across a range of health technologies used across the care pathway for post–COVID-19 condition. An overarching goal of the Panel is to support cross-jurisdictional collaboration; reduce duplication in research efforts; and broadly share, mobilize, and implement results.
The Panel has representation from cross-jurisdictional decision-makers, clinicians actively working in the area of post–COVID-19 condition, researchers, and patient representatives.
Objectives
The Panel will be engaged throughout the course of a Condition-Level Review, with specific objectives including:
- identifying and prioritizing evidence needs for us and ours collaborators to pursue
- advising on the development of an online platform to showcase results from the Panel’s efforts and the Condition-Level Review, serving as a knowledge hub for ongoing and completed research on post–COVID-19 condition, ensuring usability and functionality to support decision-making needs
- identifying the need for an expert committee (e.g., the Health Technology Expert Review Panel) recommendations based on results of a Condition-Level Review in response to specific decision needs
- sharing, and where feasible, mobilizing results of a post–COVID-19 Condition-Level Review, and online platform.
Table 1: The Pan-Canadian Stakeholder Panel on Post–COVID-19 Condition
| Organization or specialty | Name and position |
|---|---|
| Alberta Health Services | Christopher Burnie — Manager, Health Link, Specialized Services, Alberta Health Services Post–COVID Task Force |
| Scott Fullmer — Manager, Research Evidence and Policy | |
| Isabel Henderson — Executive Director, Special Projects, and Co-Chair of the Alberta Health Services Post–COVID Task Force | |
| Chester Ho — Senior Medical Director, Alberta Health Services | |
| CDA-AMC | Sinwan Basharat — Program Development Officer |
| Gino De Angelis — Manager, Clinical Research | |
| Sarah Garland — Knowledge Mobilization Officer | |
| Amanda Manoharan — Program Development Officer | |
| Laura Weeks — Director, Health Technology Assessment | |
| Clinical experts | Angela Cheung — Senior Scientist, Toronto General Hospital Research Institute |
| Simon Décary — Assistant Professor, University of Sherbrooke | |
| Adeera Levin — Professor of Medicine, University of British Columbia | |
| Ministry of Long-Term Care, Ontario | Anne Hayes — Director, Research Analysis and Evaluation |
| Stephanie Kronfli — Senior Policy Advisor | |
| Andrea Proctor — Manager, Evidence Synthesis | |
| Patient representatives | Jaymie Firkus — Long COVID Canada |
| Beth Ann Pardo | |
| Public Health Agency of Canada | Alejandra Jaramillo Garcia — Manager, Science Policy Unit |
| Francesca Reyes Domingo — Senior Epidemiologist | |
| Meghan Grainger — Evidence Synthesis and Knowledge Translation |
Last Updated : July 27, 2024